- Biogen makes a new Alzheimer’s drug costs $56,000 each year.People who are eligible for the drug also will need expensive tests like PET scans or spinal taps.
The eye-popping $56,000 price tag on Biogen’s newly approved Alzheimer’s medication has generated significant debate on the value of a drug not yet proven to slow the mind-robbing disease.
But Aduhelm’s price is only the start of what consumers and insurers might pay to get the first new Food and Drug Administration-approved drug to treat Alzheimer’s since 2003.
Many experts say patients will need expensive tests to verify they have the underlying sticky clumps of protein the drug targets in the brains of
→ Continue reading at USA Today News